Lloyd Tanner

519 total citations
20 papers, 335 citations indexed

About

Lloyd Tanner is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Lloyd Tanner has authored 20 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Lloyd Tanner's work include Cancer therapeutics and mechanisms (6 papers), Tuberculosis Research and Epidemiology (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). Lloyd Tanner is often cited by papers focused on Cancer therapeutics and mechanisms (6 papers), Tuberculosis Research and Epidemiology (5 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (4 papers). Lloyd Tanner collaborates with scholars based in Sweden, United States and South Africa. Lloyd Tanner's co-authors include Andrew Single, Lubbe Wiesner, Richard K. Haynes, Arne Egesten, Digby F. Warner, István Boldogh, Lang Pan, Ravi K. V. Bhongir, Paolo Denti and Ganna Petruk and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Lloyd Tanner

20 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lloyd Tanner Sweden 11 144 107 63 51 44 20 335
Joseph M. Grimes United States 8 118 0.8× 87 0.8× 124 2.0× 69 1.4× 50 1.1× 11 416
Adela Cota‐Gomez United States 11 198 1.4× 146 1.4× 94 1.5× 70 1.4× 100 2.3× 14 509
Krunoslav Nujić Croatia 9 96 0.7× 69 0.6× 61 1.0× 104 2.0× 83 1.9× 15 379
Caio César Barbosa Bomfim Brazil 11 113 0.8× 55 0.5× 75 1.2× 108 2.1× 77 1.8× 15 312
Mengxuan Wang China 11 132 0.9× 39 0.4× 73 1.2× 26 0.5× 33 0.8× 39 333
Shuangquan Yan China 12 128 0.9× 58 0.5× 65 1.0× 15 0.3× 70 1.6× 27 363
Yuting Wu China 14 178 1.2× 52 0.5× 21 0.3× 64 1.3× 40 0.9× 33 399
Siddhartha Majumdar India 13 180 1.3× 105 1.0× 44 0.7× 34 0.7× 19 0.4× 21 445
Safrun Mahmood India 13 99 0.7× 44 0.4× 50 0.8× 31 0.6× 41 0.9× 41 354
Krist Helen Antunes Brazil 9 100 0.7× 68 0.6× 31 0.5× 70 1.4× 73 1.7× 21 251

Countries citing papers authored by Lloyd Tanner

Since Specialization
Citations

This map shows the geographic impact of Lloyd Tanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd Tanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd Tanner more than expected).

Fields of papers citing papers by Lloyd Tanner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd Tanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd Tanner. The network helps show where Lloyd Tanner may publish in the future.

Co-authorship network of co-authors of Lloyd Tanner

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd Tanner. A scholar is included among the top collaborators of Lloyd Tanner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd Tanner. Lloyd Tanner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhongir, Ravi K. V., Médea Padra, Pernilla Lång, et al.. (2024). Macrophage expressed tartrate‐resistant acid phosphatase 5 promotes pulmonary fibrosis progression. Immunology. 171(4). 583–594. 6 indexed citations
2.
Padra, Médea, et al.. (2024). A novel quinoline with airway relaxant effects and anti-inflammatory properties. Respiratory Research. 25(1). 146–146. 2 indexed citations
3.
Pan, Lang, Spiros Vlahopoulos, Ke Wang, et al.. (2023). Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1. Frontiers in Immunology. 14. 1161160–1161160. 7 indexed citations
4.
Pan, Lang, Spiros Vlahopoulos, Lloyd Tanner, et al.. (2023). Substrate-specific binding of 8-oxoguanine DNA glycosylase 1 (OGG1) reprograms mucosal adaptations to chronic airway injury. Frontiers in Immunology. 14. 1186369–1186369. 9 indexed citations
5.
Tanner, Lloyd, Andrew Single, Ravi K. V. Bhongir, et al.. (2023). Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model. Nature Communications. 14(1). 643–643. 52 indexed citations
6.
Pan, Lang, Wenjing Hao, Ke Wang, et al.. (2023). 8-Oxoguanine targeted by 8-oxoguanine DNA glycosylase 1 (OGG1) is central to fibrogenic gene activation upon lung injury. Nucleic Acids Research. 51(3). 1087–1102. 22 indexed citations
7.
Tanner, Lloyd, et al.. (2022). Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis. Frontiers in Pharmacology. 13. 899469–899469. 4 indexed citations
8.
Zheng, Xu, Ke Wang, Lang Pan, et al.. (2022). Innate Immune Responses to RSV Infection Facilitated by OGG1, an Enzyme Repairing Oxidatively Modified DNA Base Lesions. Journal of Innate Immunity. 14(6). 593–614. 18 indexed citations
9.
Tanner, Lloyd, Ravi K. V. Bhongir, Manoj Puthia, et al.. (2022). Tartrate resistant acid phosphatase 5 (TRAP5) mediates immune cell recruitment in a murine model of pulmonary bacterial infection. Frontiers in Immunology. 13. 1079775–1079775. 6 indexed citations
10.
Tanner, Lloyd, Ravi K. V. Bhongir, Lang Pan, et al.. (2022). Pharmacological OGG1 inhibition decreases murine allergic airway inflammation. Frontiers in Pharmacology. 13. 999180–999180. 14 indexed citations
11.
Puthia, Manoj, Lloyd Tanner, Ganna Petruk, & Artur Schmidtchen. (2022). Experimental Model of Pulmonary Inflammation Induced by SARS-CoV-2 Spike Protein and Endotoxin. ACS Pharmacology & Translational Science. 5(3). 141–148. 14 indexed citations
12.
Tanner, Lloyd, et al.. (2021). Intracellular Accumulation of Novel and Clinically Used TB Drugs Potentiates Intracellular Synergy. Microbiology Spectrum. 9(2). e0043421–e0043421. 7 indexed citations
13.
Tanner, Lloyd, Ravi K. V. Bhongir, Christofer Karlsson, et al.. (2020). Citrullination of extracellular histone H3.1 reduces antibacterial activity and exacerbates its proteolytic degradation. Journal of Cystic Fibrosis. 20(2). 346–355. 13 indexed citations
14.
Tanner, Lloyd, Richard K. Haynes, & Lubbe Wiesner. (2020). Accumulation of TB-Active Compounds in Murine Organs Relevant to Infection by Mycobacterium tuberculosis. Frontiers in Pharmacology. 11. 724–724. 5 indexed citations
15.
Mueller, Rudolf, Aloysius T. Nchinda, Dale Taylor, et al.. (2020). Lerisetron Analogues with Antimalarial Properties: Synthesis, Structure–Activity Relationship Studies, and Biological Assessment. ACS Omega. 5(12). 6967–6982. 15 indexed citations
16.
Tanner, Lloyd, Richard K. Haynes, & Lubbe Wiesner. (2019). An in vitro ADME and in vivo Pharmacokinetic Study of Novel TB-Active Decoquinate Derivatives. Frontiers in Pharmacology. 10. 120–120. 16 indexed citations
17.
Tanner, Lloyd, Joanna C. Evans, Ronnett Seldon, et al.. (2019). In Vitro Efficacies, ADME, and Pharmacokinetic Properties of Phenoxazine Derivatives Active against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 63(11). 25 indexed citations
18.
Tanner, Lloyd & Andrew Single. (2019). Animal Models Reflecting Chronic Obstructive Pulmonary Disease and Related Respiratory Disorders: Translating Pre-Clinical Data into Clinical Relevance. Journal of Innate Immunity. 12(3). 203–225. 75 indexed citations
19.
Tanner, Lloyd, Paolo Denti, Lubbe Wiesner, & Digby F. Warner. (2018). Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development. IUBMB Life. 70(9). 926–937. 24 indexed citations
20.
Horner, Heidi C., Frédérique Bard, Damien Hall, et al.. (1992). Permeation of the Blood-Brain Barrier for Drug Delivery to the Brain. PsycEXTRA Dataset. 120. 218–29. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph M. Grimes Breakdown of academic impact, for papers by Adela Cota‐Gomez Breakdown of academic impact, for papers by Krunoslav Nujić Breakdown of academic impact, for papers by Caio César Barbosa Bomfim Breakdown of academic impact, for papers by Mengxuan Wang Breakdown of academic impact, for papers by Shuangquan Yan Breakdown of academic impact, for papers by Yuting Wu Breakdown of academic impact, for papers by Siddhartha Majumdar Breakdown of academic impact, for papers by Safrun Mahmood Breakdown of academic impact, for papers by Krist Helen Antunes
Rankless by CCL
2026